The global market for Wearable Drug Delivery Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Wearable Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Drug Delivery Systems.
The Wearable Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Wearable Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wearable Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Enable Injections
Unilife Corporation
West Pharma
Eitan Medical
BD Medical
Noble International
Insulet
Amgen
Roche
CeQur
ScPharmaceuticals
Segment by Type
Electronical Drug Delivery Devices
Mechanical Drug Delivery Devices
Segment by Application
Hospital
Clinic
Home Care
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wearable Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wearable Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Wearable Drug Delivery Systems Market Overview
1.1 Product Definition
1.2 Wearable Drug Delivery Systems by Type
1.2.1 Global Wearable Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031)
1.2.2 Electronical Drug Delivery Devices
1.2.3 Mechanical Drug Delivery Devices
1.3 Wearable Drug Delivery Systems by Application
1.3.1 Global Wearable Drug Delivery Systems Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Global Wearable Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Wearable Drug Delivery Systems Revenue 2020-2031
1.4.2 Global Wearable Drug Delivery Systems Sales 2020-2031
1.4.3 Global Wearable Drug Delivery Systems Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Wearable Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Wearable Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)
2.2 Global Wearable Drug Delivery Systems Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Wearable Drug Delivery Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Wearable Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Wearable Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Wearable Drug Delivery Systems, Product Type & Application
2.7 Global Key Manufacturers of Wearable Drug Delivery Systems, Date of Enter into This Industry
2.8 Global Wearable Drug Delivery Systems Market Competitive Situation and Trends
2.8.1 Global Wearable Drug Delivery Systems Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Wearable Drug Delivery Systems Players Market Share by Revenue
2.8.3 Global Wearable Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Wearable Drug Delivery Systems Market Scenario by Region
3.1 Global Wearable Drug Delivery Systems Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Wearable Drug Delivery Systems Sales by Region: 2020-2031
3.2.1 Global Wearable Drug Delivery Systems Sales by Region: 2020-2025
3.2.2 Global Wearable Drug Delivery Systems Sales by Region: 2026-2031
3.3 Global Wearable Drug Delivery Systems Revenue by Region: 2020-2031
3.3.1 Global Wearable Drug Delivery Systems Revenue by Region: 2020-2025
3.3.2 Global Wearable Drug Delivery Systems Revenue by Region: 2026-2031
3.4 North America Wearable Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Wearable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Wearable Drug Delivery Systems Sales by Country (2020-2031)
3.4.3 North America Wearable Drug Delivery Systems Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Wearable Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Wearable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Wearable Drug Delivery Systems Sales by Country (2020-2031)
3.5.3 Europe Wearable Drug Delivery Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Wearable Drug Delivery Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Wearable Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Wearable Drug Delivery Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Wearable Drug Delivery Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Wearable Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Wearable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Wearable Drug Delivery Systems Sales by Country (2020-2031)
3.7.3 Latin America Wearable Drug Delivery Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Wearable Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Wearable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Wearable Drug Delivery Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Wearable Drug Delivery Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Wearable Drug Delivery Systems Sales by Type (2020-2031)
4.1.1 Global Wearable Drug Delivery Systems Sales by Type (2020-2025)
4.1.2 Global Wearable Drug Delivery Systems Sales by Type (2026-2031)
4.1.3 Global Wearable Drug Delivery Systems Sales Market Share by Type (2020-2031)
4.2 Global Wearable Drug Delivery Systems Revenue by Type (2020-2031)
4.2.1 Global Wearable Drug Delivery Systems Revenue by Type (2020-2025)
4.2.2 Global Wearable Drug Delivery Systems Revenue by Type (2026-2031)
4.2.3 Global Wearable Drug Delivery Systems Revenue Market Share by Type (2020-2031)
4.3 Global Wearable Drug Delivery Systems Price by Type (2020-2031)
5 Segment by Application
5.1 Global Wearable Drug Delivery Systems Sales by Application (2020-2031)
5.1.1 Global Wearable Drug Delivery Systems Sales by Application (2020-2025)
5.1.2 Global Wearable Drug Delivery Systems Sales by Application (2026-2031)
5.1.3 Global Wearable Drug Delivery Systems Sales Market Share by Application (2020-2031)
5.2 Global Wearable Drug Delivery Systems Revenue by Application (2020-2031)
5.2.1 Global Wearable Drug Delivery Systems Revenue by Application (2020-2025)
5.2.2 Global Wearable Drug Delivery Systems Revenue by Application (2026-2031)
5.2.3 Global Wearable Drug Delivery Systems Revenue Market Share by Application (2020-2031)
5.3 Global Wearable Drug Delivery Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gerresheimer
6.1.1 Gerresheimer Company Information
6.1.2 Gerresheimer Description and Business Overview
6.1.3 Gerresheimer Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gerresheimer Wearable Drug Delivery Systems Product Portfolio
6.1.5 Gerresheimer Recent Developments/Updates
6.2 Owen Mumford
6.2.1 Owen Mumford Company Information
6.2.2 Owen Mumford Description and Business Overview
6.2.3 Owen Mumford Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Owen Mumford Wearable Drug Delivery Systems Product Portfolio
6.2.5 Owen Mumford Recent Developments/Updates
6.3 Sonceboz
6.3.1 Sonceboz Company Information
6.3.2 Sonceboz Description and Business Overview
6.3.3 Sonceboz Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sonceboz Wearable Drug Delivery Systems Product Portfolio
6.3.5 Sonceboz Recent Developments/Updates
6.4 United Therapeutics
6.4.1 United Therapeutics Company Information
6.4.2 United Therapeutics Description and Business Overview
6.4.3 United Therapeutics Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 United Therapeutics Wearable Drug Delivery Systems Product Portfolio
6.4.5 United Therapeutics Recent Developments/Updates
6.5 Ypsomed
6.5.1 Ypsomed Company Information
6.5.2 Ypsomed Description and Business Overview
6.5.3 Ypsomed Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ypsomed Wearable Drug Delivery Systems Product Portfolio
6.5.5 Ypsomed Recent Developments/Updates
6.6 Elcam Medical
6.6.1 Elcam Medical Company Information
6.6.2 Elcam Medical Description and Business Overview
6.6.3 Elcam Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Elcam Medical Wearable Drug Delivery Systems Product Portfolio
6.6.5 Elcam Medical Recent Developments/Updates
6.7 Enable Injections
6.7.1 Enable Injections Company Information
6.7.2 Enable Injections Description and Business Overview
6.7.3 Enable Injections Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Enable Injections Wearable Drug Delivery Systems Product Portfolio
6.7.5 Enable Injections Recent Developments/Updates
6.8 Unilife Corporation
6.8.1 Unilife Corporation Company Information
6.8.2 Unilife Corporation Description and Business Overview
6.8.3 Unilife Corporation Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Unilife Corporation Wearable Drug Delivery Systems Product Portfolio
6.8.5 Unilife Corporation Recent Developments/Updates
6.9 West Pharma
6.9.1 West Pharma Company Information
6.9.2 West Pharma Description and Business Overview
6.9.3 West Pharma Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 West Pharma Wearable Drug Delivery Systems Product Portfolio
6.9.5 West Pharma Recent Developments/Updates
6.10 Eitan Medical
6.10.1 Eitan Medical Company Information
6.10.2 Eitan Medical Description and Business Overview
6.10.3 Eitan Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eitan Medical Wearable Drug Delivery Systems Product Portfolio
6.10.5 Eitan Medical Recent Developments/Updates
6.11 BD Medical
6.11.1 BD Medical Company Information
6.11.2 BD Medical Description and Business Overview
6.11.3 BD Medical Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BD Medical Wearable Drug Delivery Systems Product Portfolio
6.11.5 BD Medical Recent Developments/Updates
6.12 Noble International
6.12.1 Noble International Company Information
6.12.2 Noble International Description and Business Overview
6.12.3 Noble International Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Noble International Wearable Drug Delivery Systems Product Portfolio
6.12.5 Noble International Recent Developments/Updates
6.13 Insulet
6.13.1 Insulet Company Information
6.13.2 Insulet Description and Business Overview
6.13.3 Insulet Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Insulet Wearable Drug Delivery Systems Product Portfolio
6.13.5 Insulet Recent Developments/Updates
6.14 Amgen
6.14.1 Amgen Company Information
6.14.2 Amgen Description and Business Overview
6.14.3 Amgen Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Amgen Wearable Drug Delivery Systems Product Portfolio
6.14.5 Amgen Recent Developments/Updates
6.15 Roche
6.15.1 Roche Company Information
6.15.2 Roche Description and Business Overview
6.15.3 Roche Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Roche Wearable Drug Delivery Systems Product Portfolio
6.15.5 Roche Recent Developments/Updates
6.16 CeQur
6.16.1 CeQur Company Information
6.16.2 CeQur Description and Business Overview
6.16.3 CeQur Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.16.4 CeQur Wearable Drug Delivery Systems Product Portfolio
6.16.5 CeQur Recent Developments/Updates
6.17 ScPharmaceuticals
6.17.1 ScPharmaceuticals Company Information
6.17.2 ScPharmaceuticals Description and Business Overview
6.17.3 ScPharmaceuticals Wearable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.17.4 ScPharmaceuticals Wearable Drug Delivery Systems Product Portfolio
6.17.5 ScPharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Wearable Drug Delivery Systems Industry Chain Analysis
7.2 Wearable Drug Delivery Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Wearable Drug Delivery Systems Production Mode & Process Analysis
7.4 Wearable Drug Delivery Systems Sales and Marketing
7.4.1 Wearable Drug Delivery Systems Sales Channels
7.4.2 Wearable Drug Delivery Systems Distributors
7.5 Wearable Drug Delivery Systems Customer Analysis
8 Wearable Drug Delivery Systems Market Dynamics
8.1 Wearable Drug Delivery Systems Industry Trends
8.2 Wearable Drug Delivery Systems Market Drivers
8.3 Wearable Drug Delivery Systems Market Challenges
8.4 Wearable Drug Delivery Systems Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Gerresheimer
Owen Mumford
Sonceboz
United Therapeutics
Ypsomed
Elcam Medical
Enable Injections
Unilife Corporation
West Pharma
Eitan Medical
BD Medical
Noble International
Insulet
Amgen
Roche
CeQur
ScPharmaceuticals
听
听
*If Applicable.
